By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Life Technologies will distribute and sell Quidel's molecular diagnostic assays in Europe under an agreement announced today.

Beginning next month, Life Tech will begin selling two Quidel molecular diagnostic tests — the Influenza A+B Real-Time RT-PCR Assay and the human metapneumovirus (hMPV) assays. Quidel had announced yesterday that its hMPV test had received the CE Mark. Its influzenza test received the CE Mark in August.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.